TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer
==========================================================================================================================================================================================================================

* David B Rosen
* Anne Månsson Kvarnhammar
* Burkhardt Laufer
* Thomas Knappe
* Jens Jakob Karlsson
* Enping Hong
* Yu-Chi Lee
* Dhruv Thakar
* Luis Alejandro Zúñiga
* Kathy Bang
* Simran Singh Sabharwal
* Karan Uppal
* Janne Damm Olling
* Kristian Kjaergaard
* Thomas Kurpiers
* Meike Schnabel
* Diana Reich
* Philipp Glock
* Joachim Zettler
* Mathias Krusch
* Ana Bernhard
* Stefan Heinig
* Valentino Konjik
* Thomas Wegge
* Yvonne Hehn
* Steffen Killian
* Laura Viet
* Josefine Runz
* Frank Faltinger
* Mohammad Tabrizi
* Kristin Laura Abel
* Vibeke Miller Breinholt
* Stina M Singel
* Kennett Sprogøe
* Juha Punnonen